Healthcare -
Biotechnology - NASDAQ - US
$ 7.2
-2.3 %
$ 6 M
Market Cap
-0.01
P/E
RNAZ - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RNAZ - TransCode Therapeutics, Inc.
-21.8 K
LAST VALUE
53.56%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR